Abstract
Lipid matrix nanoparticles, such as solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), have been sought as a useful alternative for formulating poorly soluble drugs intended for several administration routes, e.g. oral, parenteral and topical. These systems are surfaced by a film of surfactant in an aqueous phase, being therefore physicochemically and thermodynamically stable having a mean particle size below 1 µm. The matrix of SLN is solely composed of a pure solid lipid (melting point above 40°C) whereas NLC is composed of a blend of solid and liquid lipids, which must also be solid at both body and room temperatures. The achievements of SLN and NLC as drug carrier systems are due to several advantages, e.g. incorporation of hydrophobic and hydrophilic drug molecules (including peptides and proteins), controlled release, protection of chemically labile drugs, fulfil several prerequisites for an optimum colloidal drug carrier. The present review aims to emphasize the special features of lipid matrix nanoparticles, in particular for controlled release purposes. An overview on pharmacokinetic and biopharmaceutic results achieved by different research groups is given and their parameters are analyzed.
Keywords: Lipid nanoparticles, lipid polymorphism, controlled release, oral, parenteral, topical
Current Nanoscience
Title: Lipid Matrix Nanoparticles: Pharmacokinetics and Biopharmaceutics
Volume: 5 Issue: 3
Author(s): Doktorovova S., Gokce E., Ozyazici M. and Souto E. B.
Affiliation:
Keywords: Lipid nanoparticles, lipid polymorphism, controlled release, oral, parenteral, topical
Abstract: Lipid matrix nanoparticles, such as solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), have been sought as a useful alternative for formulating poorly soluble drugs intended for several administration routes, e.g. oral, parenteral and topical. These systems are surfaced by a film of surfactant in an aqueous phase, being therefore physicochemically and thermodynamically stable having a mean particle size below 1 µm. The matrix of SLN is solely composed of a pure solid lipid (melting point above 40°C) whereas NLC is composed of a blend of solid and liquid lipids, which must also be solid at both body and room temperatures. The achievements of SLN and NLC as drug carrier systems are due to several advantages, e.g. incorporation of hydrophobic and hydrophilic drug molecules (including peptides and proteins), controlled release, protection of chemically labile drugs, fulfil several prerequisites for an optimum colloidal drug carrier. The present review aims to emphasize the special features of lipid matrix nanoparticles, in particular for controlled release purposes. An overview on pharmacokinetic and biopharmaceutic results achieved by different research groups is given and their parameters are analyzed.
Export Options
About this article
Cite this article as:
S. Doktorovova, E. Gokce, M. Ozyazici and B. E. Souto, Lipid Matrix Nanoparticles: Pharmacokinetics and Biopharmaceutics, Current Nanoscience 2009; 5 (3) . https://dx.doi.org/10.2174/157341309788921516
DOI https://dx.doi.org/10.2174/157341309788921516 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiovascular Risk in Patients with Primary Hyperparathyroidism
Current Pharmaceutical Design Comparative Study of Nutritional and Phytochemical Attributes of Andrographis paniculata, Bryophyllum pinnatum and Clitoria ternatea for Nutraceutical Applications
Current Nutrition & Food Science Expanding the Therapeutic Potential of Statins by Means of Nanotechnology Enabled Drug Delivery Systems
Current Topics in Medicinal Chemistry Immunomodulatory Effect of Probiotic Bacteria
Recent Patents on Inflammation & Allergy Drug Discovery Heterogeneity of Pre-diabetes and Type 2 Diabetes: Implications for Prediction, Prevention and Treatment Responsiveness
Current Diabetes Reviews Atypical Neurotransmitters and the Neurobiology of Depression
CNS & Neurological Disorders - Drug Targets Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism The Role of Infections in the Pathogenesis of Autoimmune Diseases
Current Drug Targets - Inflammation & Allergy Editorial (Thematic Issue: Metabolic Disorders, Drug Development, Drug Design and Biomarkers)
Current Pharmaceutical Design Analysis of Parallel SVM Based Classification Technique on Healthcare using Big Data Management in Cloud Storage
Recent Patents on Computer Science Sex-Genetic Interaction in the Risk for Cerebrovascular Disease
Current Medicinal Chemistry Chalcones as Versatile Synthons for the Synthesis of 5- and 6-membered Nitrogen Heterocycles
Current Organic Chemistry Molecular Targets and Natural Compounds in Drug Development for the Treatment of Inflammatory Pain
Current Drug Targets Supraventricular Tachycardia in Fetus: How Can We Treat ?
Current Pharmaceutical Design Moving Troponin Testing into the 21st Century: Will Greater Sensitivity Be Met with Greater Sensibility?
Cardiovascular & Hematological Disorders-Drug Targets Insulin Secretion and Interleukin-1β Dependent Mechanisms in Human Diabetes Remission After Metabolic Surgery
Current Medicinal Chemistry Editorial [Hot topic: Current Topics on Hypolipidaemic Therapy and Cardiovascular Risk Assessment (Guest Editors: Evangelos C. Rizos and Moses S. Elisaf)]
Current Vascular Pharmacology Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
Current Drug Targets Evaluation and Exploitation of Bioactive Compounds of Walnut, Juglans regia
Current Pharmaceutical Design Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer
Current Drug Targets